In non-diabetic patients, this medication: Stimulates insulin release from the pancreas, but only when blood sugar is elevated Slows stomach emptying, which reduces glucagon secretion (a hormone that raises blood sugar) Decreases appetite and food intake Heres the key point: GLP-1 medications stimulate insulin release only when blood sugar levels are elevated
But lessons from U.S
These GLP-1 medications, as theyre commonly known, cause the same effects
The high retail price reflects pharmaceutical company pricing strategies, patent protections, and the enormous demand for effective weight loss medications
GLOBAL GLUTATHIONE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION) TABLE 191
Author: Yuzhao Huang, Yuchen He , Meagan J